The European Commission on Feb. 5 cleared Shanghai Henlius Biotech Inc.’s serplulimab (HLX-02) under the brand name of Hetronifly as a first-line combination therapy with carboplatin and etoposide to ...

SEER data show that small cell lung cancer (SCLS) incidence has steadily declined due to reduced smoking rates, but survival outcomes have seen only minimal improvement, underscoring the need for more ...

Shanghai Henlius Biotech, Inc. (2696.HK) announced that its anti-PD-1 mAb, HANSIZHUANG (serplulimab, marketed as Hetronifly® in Europe), has been officially approved by the European Commission (EC) ...

Metronomic chemotherapy (MC) is emerging as a groundbreaking treatment for pediatric neuroblastoma, offering a more accessible and manageable option for children with high-risk and relapsed/refractory ...

近年来，全球肿瘤研究与诊疗领域仿若被按下了“加速键”，呈现出一派蓬勃发展之势，为无数患者带来新的希望曙光。

Youdao, Inc. ("Youdao" or the "Company") , an intelligent learning company with industry-leading technology in China, today announced that it will report its fourth quarter and fiscal year 2024 ...

Metronomic chemotherapy (MC) is emerging as a groundbreaking treatment for pediatric neuroblastoma, offering a more accessible and manageable option ...

At close: February 3 at 4:00:00 PM EST ...

The International Agency for Research on Cancer (IARC) Monographs (www.monographs.iarc.fr) identify environmental and occupational causes of human cancer. Sometimes called the WHO “Encyclopedia of ...

The dominant rationale to generate new (and to assess old) anticancer chemotherapeutic agents is to determine their cell-autonomous effects — that is, their capacity to reduce the growth ...

During the past 20 years, the advent of neoadjuvant, primary, and adjuvant concurrent chemoradiotherapy has improved cancer care dramatically. Significant contributions have been made by ...